The effect of activin A, an antagonist of IL-1 and IL-6, on osteoclast formation.

激活素 A(IL-1 和 IL-6 的拮抗剂)对破骨细胞形成的影响。

基本信息

  • 批准号:
    10557169
  • 负责人:
  • 金额:
    $ 5.06万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

The skeleton is a dynamic organ in which mineralized bone is continuously resorbed by osteoclasts, and new bone is formed by osteoblasts. This process, known as bone remodeling, is normally highly regulated with maintenance of a normal amount of bone. Chronic infection of the periodontal tissue and menopause put the process out of balance and enhance bone resorption by stimulating production of factors such as interleukin-1 (IL-1) and IL-6. Our previous study demonstrated that activin A, a member of transforming growth factor beta (TGF-β), inhibited the production of IL-1β and enhanced secretion of IL-1 receptor antagonist in monocytic cells stimulated by phorbol ester and lipopolysaccharide. Activin-A also inhibits the biological activities of IL-6 in various types of cells. In this study, we examined the role of TGF-β family members including activin-A in the osteoclast formation and obtained interesting results as follows : when mouse bone marrow cells were co-cultured with bone stromal cells, all the TGF-β family members tested (TGF-β1, activin-A, BMP-2) stimulated vitamin D3- and IL-1α-mediated osteoclast formation ; enhancement of osteoclast formation by BMP-2 appeared to be mediated through accumulation of osteoclast differentiation factor (ODF) mRNA in bone stromal cells ; when bone marrow cells were cultured in the presence of M-CSF and ODF, activin-A strongly enhanced osteoclast formation. These results suggest that TGF-β family members play an important role in osteoclastogenesis and that inhibitors of activin-A can be used as a therapeutic agent of osteoporosis and periodontitis.
骨骼是一种动态器官,其中矿化骨被破骨细胞不断吸收,而新骨则由成骨细胞形成。这种称为骨重塑的过程通常受到正常骨骼的维持高度调节。牙周组织和更年期的慢性感染使该过程失去平衡,并通过刺激诸如白介素-1(IL-1)和IL-6等因素的产生来增强骨骼分辨率。我们先前的研究表明,转化生长因子β(TGF-β)的成员AIVICIN A抑制了IL-1β的产生,并增强了由佛波酯和脂多糖刺激的单核细胞中IL-1受体拮抗剂的分泌。 Activin-A还抑制了各种细胞中IL-6的生物学活性。 In this study, we examined the role of TGF-β family members including activin-A in the osteoclast formation and obtained interesting results as Follows: when mouse bone marrow cells were co-cultured with bone stromal cells, all the TGF-β family members tested (TGF-β1, activin-A, BMP-2) stimulated vitamin D3- and IL-1α-mediated osteoclast formation; BMP-2通过骨基质细胞中的破骨细胞分化因子(ODF)mRNA的积累而介导的破骨细胞形成似乎是介导的。当在M-CSF和ODF的存在下培养骨髓细胞时,激活素A可以强烈增强的破骨细胞形成。这些结果表明,TGF-β家族成员在骨质质构成中起重要作用,并且激活蛋白A的抑制剂可以用作骨质疏松症和牙周炎的治疗剂。

项目成果

期刊论文数量(35)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Muto,A.: "1,25-Dihydroxyvitamine D3 induces differentiation of retinoic acid-resistant APL cell Line(UF-1)associated with p21^<WAF1/CIP1> and p27^<KIP1>." Blood. (in press). (1999)
Muto,A.:“1,25-二羟基维生素 D3 诱导与 p21^<WAF1/CIP1> 和 p27^<KIP1> 相关的抗视黄酸 APL 细胞系 (UF-1) 的分化。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ishisaki, A .et al.: "Differential inhibition of Smad6 and Smad7 on Bone morphogenetic protein-and activin-mediated growth arrest and apoptosis in B cells."J. Biol. Chem.. 274. 13637-13942 (1999)
Ishisaki, A 等人:“Smad6 和 Smad7 对 B 细胞中骨形态发生蛋白和激活素介导的生长停滞和凋亡的差异抑制。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamato, K., Hashimoto, S., Okahashi, N., Ishisaki, A., Nonaka, K., Koseki, T., Kizaki, M., Ikeda, Y., Nishihara, T.: "Dissociation of bone morphogenetic protein-mediated growth arrest and apoptosis of mouse B cells by HPV-16 E6/E7."Exp. Cell Res.. (in pre
Yamato, K.、Hashimoto, S.、Okahashi, N.、Ishisaki, A.、Nonaka, K.、Koseki, T.、Kizaki, M.、Ikeda, Y.、Nishihara, T.:“骨形态发生的分离
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ishisaki, A., Yamato, K., Hashimoto, S., Nakao, A., Tamaki, K., Nonaka, K., ten Dijke, P., Sugino, H., Nishihara, T.: "Differential inhibition of Smad6 and Smad7 on Bone morphogenetic protein-and activin-mediated growth arrest and apoptosis in B cells."J.
石崎,A.,大和,K.,桥本,S.,中尾,A.,玉木,K.,野中,K.,十迪克,P.,杉野,H.,西原,T.:“差异抑制
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Muto, A., Kizaki, M., Yamato, K., Kamata, M., Ueno, H., Kawai, Y., Ohguchi, M., Nishihara, T., Koeffler, H. P., and Ikeda, Y.: "1,25-Dihydroxyvitamin D3 induces differentiation of retinoic acid-resistant APL cell line (UF-1) associated with expression of
Muto, A.、Kizaki, M.、Yamato, K.、Kamata, M.、Ueno, H.、Kawai, Y.、Ohguchi, M.、Nishihara, T.、Koeffler, H. P. 和 Ikeda, Y.:
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMATO Kenji其他文献

YAMATO Kenji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMATO Kenji', 18)}}的其他基金

Organotypic epithelial raft cultures as HPV-related cancer models for evaluating siRNA and its delivery system
器官型上皮筏培养物作为 HPV 相关癌症模型,用于评估 siRNA 及其递送系统
  • 批准号:
    22592084
  • 财政年份:
    2010
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
siRNA-mediated highly potent and specific RNAi in human culturedcells and its signals
siRNA介导的人类培养细胞中高效且特异的RNAi及其信号
  • 批准号:
    19592169
  • 财政年份:
    2007
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
In vitro and in vivo growth suppression of HPV-related cancer cells by siRNA targeting E6 oncogene
通过靶向 E6 癌基因的 siRNA 抑制 HPV 相关癌细胞的体外和体内生长
  • 批准号:
    15591991
  • 财政年份:
    2003
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inductioin and activation of p53 tumor suppressor protein by Cdt in HPV-related cancer cells
Cdt 在 HPV 相关癌细胞中诱导和激活 p53 肿瘤抑制蛋白
  • 批准号:
    13671962
  • 财政年份:
    2001
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Anti-myeloma activity of members of the TGF-β family with induction of growth arrest and apoptosis^*
TGF-β 家族成员的抗骨髓瘤活性,诱导生长停滞和细胞凋亡^*
  • 批准号:
    12557157
  • 财政年份:
    2000
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of Smads and TAK1 in BMP-induced growth arrest and apoptosis
Smads 和 TAK1 在 BMP 诱导的生长停滞和细胞凋亡中的作用
  • 批准号:
    11671797
  • 财政年份:
    1999
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Intracellular signals of activin-A mediating growtharrest and apoptosis
激活素 A 的细胞内信号介导生长停滞和细胞凋亡
  • 批准号:
    09671847
  • 财政年份:
    1997
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

METTL1上调破骨细胞BMP2 UFMylation修饰在强直性脊柱炎病理性成骨中的作用机制研究
  • 批准号:
    82372372
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
BMPR1a的SUMO化修饰通过调控BMP受体寡聚化促进类风湿关节炎破骨细胞分化活化的机制研究
  • 批准号:
    82071818
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
Ⅰ型BMP受体BMPR1B介导的BMP信号与WNT信号交叉对话在骨重塑中的作用机理研究
  • 批准号:
    81600843
  • 批准年份:
    2016
  • 资助金额:
    17.0 万元
  • 项目类别:
    青年科学基金项目
基于MAPK和β-catenin/BMP信号通路探讨天然药物对感染性骨疾病骨生长重建的调控机制研究
  • 批准号:
    81672190
  • 批准年份:
    2016
  • 资助金额:
    25.0 万元
  • 项目类别:
    面上项目
BMP-2诱导破骨细胞活化导致骨溶解的Smad与JNK信号通路研究
  • 批准号:
    81372019
  • 批准年份:
    2013
  • 资助金额:
    70.0 万元
  • 项目类别:
    面上项目

相似海外基金

In vivo imaging of BMP-induced ectopic bone formation
BMP 诱导异位骨形成的体内成像
  • 批准号:
    17K11005
  • 财政年份:
    2017
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of osteogenic Menin in bone mass accumulation in vivo
成骨 Menin 在体内骨量积累中的作用
  • 批准号:
    350176
  • 财政年份:
    2015
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Studentship Programs
Analysis of the regulation of bone metabolism by the pool of osteoclast precursors
破骨细胞前体库对骨代谢的调节分析
  • 批准号:
    22791804
  • 财政年份:
    2010
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Analysis of function of bone morphogenetic protein signaling in bone remodeling and osteoclast formation
骨形态发生蛋白信号在骨重塑和破骨细胞形成中的功能分析
  • 批准号:
    20791033
  • 财政年份:
    2008
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Elucidation of molecular mechanism of alveolar bone remodeling induced by orthodontic force.
阐明正畸力诱导牙槽骨重塑的分子机制。
  • 批准号:
    17592155
  • 财政年份:
    2005
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了